Retraction

Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity

Paper Information

Record ID:
42403
Journal:
Publication Date:
September 02, 2013
Retraction Date:
February 02, 2023 (2.8 years years ago)
Article Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

Original article not updated with added authors/affilitions from correction: see https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093126

Citations (28)

28
Total Citations
3
Post-Retraction
(10.7%)
24
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
628 Days since retraction (latest)
Immunomodulation of human T cells by microbubble-mediated focused ultrasound
Ana G. Baez, Davindra Singh, Stephanie He et al. (7 authors)
Frontiers in Immunology Open Access
Published: Oct 2024
1 citation
628 days after retraction
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
Maryanne C. Herzig, Barbara A. Christy, Robbie K. Montgomery et al. (11 authors)
Frontiers in Immunology Open Access
Published: Sep 2023
4 citations
236 days after retraction
Prenol, but Not Vitamin C, of Fruit Binds to SARS-CoV-2 Spike S1 to Inhibit Viral Entry: Implications for COVID-19
Ramesh Kumar Paidi, Malabendu Jana, Sumita Raha et al. (7 authors)
The Journal of Immunology Open Access
Published: May 2023
7 citations
92 days after retraction
Retraction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Unknown Authors
PLoS ONE Open Access
Published: Feb 2023
Same day as retraction
Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton’s Lymphoma-induced tumor microenvironment: an in vitro and in vivo study
Rishi Kant Singh, Rishi Kant Singh, Ilya V. Ulasov et al. (5 authors)
Cancer Immunology Immunotherapy
Published: Dec 2022
4 citations
61 days before retraction
Biological implications of the immune factors in the tumour microenvironment of oral cancer
Smitha Sammith Shetty, Kanaka Sai Ram Padam, Keith D. Hunter et al. (5 authors)
Archives of Oral Biology
Published: Oct 2021
3 citations
465 days before retraction
Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
Rachel M. Golonka, Matam Vijay‐Kumar
Advances in cancer research
Published: Nov 2020
23 citations
804 days before retraction
Chimeric antigen receptor‐modified macrophages trigger systemic anti‐tumour immunity
Zhiyuan Niu, Guanxu Chen, Wei Chun Chang et al. (11 authors)
The Journal of Pathology
Published: Nov 2020
90 citations
821 days before retraction
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Su Jong Yu, Tim F. Greten
Journal of Liver Cancer Open Access
Published: Mar 2020
5 citations
1038 days before retraction
Identification of hepatitis B virus and liver cancer bridge molecules based on functional module network
Xiaobing Huang, Yonggang He, Lu Zheng et al. (8 authors)
World Journal of Gastroenterology Open Access
Published: Sep 2019
6 citations
1247 days before retraction
Deciphering the Role of Regulatory CD4 T Cells in Oral and Oropharyngeal Cancer: A Systematic Review
Caoimhín O’Higgins, Frank J. Ward, Rasha Abu Eid
Frontiers in Oncology Open Access
Published: Oct 2018
33 citations
1571 days before retraction
Attenuated accumulation of regulatory T cells and reduced production of interleukin 10 lead to the exacerbation of tissue injury in a mouse model of acute respiratory distress syndrome
Masahiko Toyama, Daisuke Kudo, Tetsuji Aoyagi et al. (9 authors)
Microbiology and Immunology Open Access
Published: Dec 2017
16 citations
1869 days before retraction
Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by <i>Ex Vivo</i> PI3K-δ Inhibition
Rasha Abu Eid, Shamim Ahmad, Yuan Lin et al. (13 authors)
Cancer Research Open Access
Published: Jun 2017
70 citations
2058 days before retraction
Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer
Baodan Yu, Junli Wang, Chen He et al. (11 authors)
Experimental and Therapeutic Medicine Open Access
Published: Jun 2017
14 citations
2065 days before retraction
The Differential Roles of PI3K P110 Isoforms in Regulating CD4 T Cell Subset Polarization
Mason Webb
Unknown Journal
Published: May 2017
2092 days before retraction
Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
Lejia Sun, Gang Xu, Wenjun Liao et al. (10 authors)
Oncotarget Open Access
Published: Apr 2017
49 citations
2113 days before retraction
Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance
Leila Akkari, Amaia Lujambio
Resistance to targeted anti-cancer therapeutics
Published: Jan 2017
1 citation
2223 days before retraction
Chemokine Receptor Signaling and the Hallmarks of Cancer
Rosa Ana Lacalle, Raquel Blanco, Lorena Carmona‐Rodríguez et al. (6 authors)
International review of cell and molecular biology
Published: Dec 2016
76 citations
2254 days before retraction
Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease
Joanna Budna, L Spychalski, Mariusz Kaczmarek et al. (7 authors)
Immunobiology
Published: Oct 2016
17 citations
2298 days before retraction
Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells
Junfeng Ye, Yuanqiang Lin, Xiuhua Yu et al. (5 authors)
International Immunopharmacology
Published: Jul 2016
7 citations
2406 days before retraction
Regulatory T‐cells promote hepatitis B virus infection and hepatocellular carcinoma progression
Wei Li, Jun Han, Hong Wu
Chronic Diseases and Translational Medicine Open Access
Published: Jun 2016
29 citations
2437 days before retraction
CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells
Yang Li, Yifei Li, Chong-Zhan Si et al. (8 authors)
Virus Research
Published: May 2016
20 citations
2464 days before retraction
The selective impact of transgenically expressed glucocorticoid receptor on T cells
Konstantin Yakimchuk, Liying Chen, Mohammad Sharif Hasni et al. (5 authors)
Autoimmunity
Published: Nov 2014
6 citations
2999 days before retraction
Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors
Christel Devaud, Jennifer A. Westwood, Michele W.L. Teng et al. (9 authors)
OncoImmunology Open Access
Published: Nov 2014
8 citations
3014 days before retraction
Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway
Rasha Abu Eid, Raed Samara, Laurent Ozbun et al. (8 authors)
Cancer Immunology Research Open Access
Published: Jul 2014
142 citations
3108 days before retraction
Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
Yong Huang, Huaiwei Liao, Yong Zhang et al. (8 authors)
PLoS ONE Open Access
Published: May 2014
72 citations
3186 days before retraction
Correction: Depletion of CD4+ CD25+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Unknown Authors
PLoS ONE Open Access
Published: Mar 2014
1 citation
3234 days before retraction
Progress of Immunotherapy for Hepatocellular Carcinoma
Hongbo Ma
ImmunoGastroenterology
Published: Jan 2013
1 citation
3684 days before retraction
Related Records

This article has multiple records in the database due to different notices:

Record #48171
Mar 27, 2014
Correction
Quick Stats
Total Citations: 28
Years Since Retraction: 2.8 years
Open Access: Yes
Last Checked: Jul 24, 2025